Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kaye

Showing results (11-20 of 499) with videos related to

Pageof 50
Sort By:
Archives of Neurology|November 16, 2002
Healthy brain agingJeffrey A Kaye
Stem Cells (Dayton, Ohio)|September 30, 2000
FDA licensure of NEUMEGA to prevent severe chemotherapy-induced thrombocytopeniaJ A Kaye
Stem Cells (Dayton, Ohio)|January 1, 1996
The clinical development of recombinant human interleukin 11 (NEUMEGA rhIL-11 growth factor)J A Kaye
The American Journal of Forensic Medicine and Pathology|March 1, 1986
Correspondence about handling evidence in cases of acquired immune deficiency syndrome (AIDS)J A Kaye
Neurology|July 23, 1998
Diagnostic challenges in dementiaJ A Kaye
Foot & Ankle International|March 1, 1994
The extra-depth toe box: a rational approachR A Kaye
Archives of Neurology|October 28, 1997
Oldest-old healthy brain function. The genomic potentialJ A Kaye
Archives of Neurology|March 14, 2000
Methods for discerning disease-modifying effects in Alzheimer disease treatment trialsJ A Kaye
Foot & Ankle|June 1, 1989
Stabilization of ankle syndesmosis injuries with a syndesmosis screwR A Kaye
Applied Optics|June 18, 2010
Nonlocal thermodynamic equilibrium effects in stratospheric HF by collisional energy transfer from electronically excited O(2) and implications for infrared remote sensingJ A Kaye
Pageof 50

Showing results (11-20 of 499) with videos related to

Sort By:
Pageof 50
Archives of Neurology|November 16, 2002
Healthy brain agingJeffrey A Kaye
Stem Cells (Dayton, Ohio)|September 30, 2000
FDA licensure of NEUMEGA to prevent severe chemotherapy-induced thrombocytopeniaJ A Kaye
Stem Cells (Dayton, Ohio)|January 1, 1996
The clinical development of recombinant human interleukin 11 (NEUMEGA rhIL-11 growth factor)J A Kaye
The American Journal of Forensic Medicine and Pathology|March 1, 1986
Correspondence about handling evidence in cases of acquired immune deficiency syndrome (AIDS)J A Kaye
Neurology|July 23, 1998
Diagnostic challenges in dementiaJ A Kaye
Foot & Ankle International|March 1, 1994
The extra-depth toe box: a rational approachR A Kaye
Archives of Neurology|October 28, 1997
Oldest-old healthy brain function. The genomic potentialJ A Kaye
Archives of Neurology|March 14, 2000
Methods for discerning disease-modifying effects in Alzheimer disease treatment trialsJ A Kaye
Foot & Ankle|June 1, 1989
Stabilization of ankle syndesmosis injuries with a syndesmosis screwR A Kaye
Applied Optics|June 18, 2010
Nonlocal thermodynamic equilibrium effects in stratospheric HF by collisional energy transfer from electronically excited O(2) and implications for infrared remote sensingJ A Kaye
Pageof 50